We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.45%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$24.5B
AUM Growth
-$766M
(-3%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
14.99%
Holding
4,039
New
907
Increased
1,143
Reduced
1,068
Closed
874
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$208M |
| 2 |
CVS Health
CVS
|
+$132M |
| 3 |
Comcast
CMCSA
|
+$114M |
| 4 |
Honeywell
HON
|
+$94.8M |
| 5 |
ConocoPhillips
COP
|
+$92.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$233M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$228M |
| 3 |
Apple
AAPL
|
+$195M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$157M |
| 5 |
Nike
NKE
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.7% |
| 2 | Consumer Discretionary | 10.58% |
| 3 | Healthcare | 6.83% |
| 4 | Industrials | 5.75% |
| 5 | Financials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
ALX Oncology
ALXO
$273M
| $286K | ﹤0.01% |
+63,231
| New | +$479K |
|
|
GATO
2602
DELISTED
Gatos Silver, Inc.
GATO
| $286K | ﹤0.01% |
+43,739
| New | +$210K |
|
|
OSG
2603
DELISTED
Overseas Shipholding Group Inc.
OSG
| $285K | ﹤0.01% |
+73,113
| New | +$263K |
|
2604
PUT
Axalta
AXTA
$7.01B
| $285K | ﹤0.01% |
+9,400
| New | +$270K |
|
2605
Eos Energy Enterprises
EOSE
$1.23B
| $284K | ﹤0.01% |
+110,654
| New | +$192K |
|
2606
Vital Farms
VITL
$558M
| $283K | ﹤0.01% |
18,484
+8,135
| +79% | +$129K |
|
2607
Cytek Biosciences
CTKB
$576M
| $283K | ﹤0.01% |
30,773
-54,660
| -64% | -$588K |
|
2608
PUT
Brighthouse Financial
BHF
$3.63B
| $282K | ﹤0.01% |
6,400
-20,800
| -76% | -$1.09M |
|
2609
FLEX LNG
FLNG
$1.67B
| $282K | ﹤0.01% |
8,403
-17,088
| -67% | -$556K |
|
2610
Cavco Industries
CVCO
$4.39B
| $282K | ﹤0.01% |
+888
| New | +$246K |
|
2611
Regional Management Corp
RM
$384M
| $282K | ﹤0.01% |
+10,803
| New | +$334K |
|
|
CSR
2612
Centerspace
CSR
$936M
| $281K | ﹤0.01% |
+5,141
| New | +$317K |
|
2613
Dyne Therapeutics
DYN
$4.04B
| $281K | ﹤0.01% |
+24,362
| New | +$316K |
|
2614
Allogene Therapeutics
ALLO
$601M
| $280K | ﹤0.01% |
56,775
-143,589
| -72% | -$921K |
|
2615
Cogent Biosciences
COGT
$6.79B
| $280K | ﹤0.01% |
25,958
-37,192
| -59% | -$476K |
|
2616
PUT
Baxter International
BAX
$11.6B
| $280K | ﹤0.01% |
6,900
-4,000
| -37% | -$170K |
|
2617
ASE Group
ASX
$80.8B
| $280K | ﹤0.01% |
+35,089
| New | +$256K |
|
2618
Fox Factory Holding Corp
FOXF
$776M
| $280K | ﹤0.01% |
+2,303
| New | +$264K |
|
2619
Energy Vault
NRGV
$522M
| $279K | ﹤0.01% |
130,190
+110,355
| +556% | +$376K |
|
2620
Halozyme
HALO
$9.72B
| $278K | ﹤0.01% |
7,276
-154,978
| -96% | -$7.27M |
|
2621
Ubiquiti
UI
$31.8B
| $278K | ﹤0.01% |
1,022
-6,750
| -87% | -$1.87M |
|
|
RC
2622
Ready Capital
RC
$265M
| $278K | ﹤0.01% |
27,300
+10,843
| +66% | +$127K |
|
2623
ProShares UltraShort Russell2000
TWM
$43.2M
| $277K | ﹤0.01% |
+3,575
| New | +$266K |
|
2624
Emergent Biosolutions
EBS
$375M
| $277K | ﹤0.01% |
26,731
+16,322
| +157% | +$197K |
|
2625
Cosan
CSAN
$2.96B
| $276K | ﹤0.01% |
+23,387
| New | +$281K |
|
Similar funds
Squarepoint's Q1 2023 Portfolio in Review
As of Q1 2023, Squarepoint held 4,039 positions worth $24.5B, down 3% from $25.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $1.16B of net new capital in Q1 2023, opening 907 new positions and adding to 1,143 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street Materials Select Sector SPDR ETF, an estimated $233M trimmed.
- Squarepoint's largest Q1 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
- Squarepoint added most to CVS Health in Q1 2023, an estimated $132M increase.
- Squarepoint's biggest Q1 2023 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $233M.
- Squarepoint fully exited Mondelez International in Q1 2023, selling an estimated $95.9M.
- Squarepoint's ten largest holdings make up 15% of its $24.5B portfolio in Q1 2023.
- Squarepoint opened 907 new positions and closed 874 in Q1 2023.
- Squarepoint's portfolio value fell 3% quarter-over-quarter to $24.5B.
Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.